Antidotes for acute cardenolide (cardiac glycoside) poisoning

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2006, Pages

  Roberts, Daren M ^a   Buckley, N A ^b  

^a Canberra Hospital   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; ANTIDOTE; ATROPINE; BICARBONATE; CARDENOLIDE; CARDIAC GLYCOSIDE; DIGOXIN ANTIBODY F(AB) FRAGMENT; FRUCTOSE 1,6 BISPHOSPHATE; ISOPRENALINE; MAGNESIUM; PHENYTOIN; PLACEBO;

ABDOMINAL DISCOMFORT; ANGIONEUROTIC EDEMA; BRONCHOSPASM; CLINICAL TRIAL; CONFIDENCE INTERVAL; DIARRHEA; DIGITALIS INTOXICATION; DRUG EFFICACY; HEART ARRHYTHMIA; HUMAN; INTOXICATION; MORTALITY; NAUSEA; OUTCOME ASSESSMENT; QUALITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT;

EID: 37649027350     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005490.pub2     Document Type: Review

References (33)

1. de Silva 2003 {published data only} de Silva HA, Fonseka MM, Pathmeswaran A, Alahakone DG, Ratnatilake GA, Gunatilake SB, Ranasinha CD, Lalloo DG, Aronson JK, de Silva HJ. Multiple-dose activated charcoal for treatment of yellow oleander poisoning: a single-blind, randomised, placebo-controlled trial. Lancet 2003;361(9373):1935-8.
2. Eddleston 2000 {published data only} Eddleston M, Rajapakse S, Rajakanthan S, Sjöström L, Santharaj W, Thenabadu PN, Sheriff MHR, Warrell DA. Anti-digoxin Fab fragments in cardiotoxicity induced by ingestion of yellow oleander: a randomised controlled trial. Lancet 2000;355(9208):967-72.
3. Albrecht 1988 Albrecht K, Hagen N, Falkowski KP, Ickert K. Treatment of the lifethreatening digitalis-intoxication with heterologous antibodies [Die behandlung der lebensbedrohlichen digitalis-intoxikation mit heterologen antikörper-fragmenten]. Zeitschrift Fur Klinische Medizin 1988;43(8):617-20.
4. Antman 1990 Antman EM, Wenger TL, Butler VP Jr, Haber E, Smith TW. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study. Circulation 1990;81(6):1744-52.
5. Eddleston 2003 Eddleston M, Senarathna L, Mohamed F, Buckley N, Juszczak E, Sheriff MHR, et al. Deaths due to absence of an affordable antitoxin for plant poisoning. Lancet 2003;362(9389):1041-4.
6. Hickey 1991 Hickey AR, Wenger TL, Carpenter VP, Tilson HH, Hlatky MA, Furberg CD, et al. Digoxin Immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study. Journal of the American College of Cardiology 1991; 17(3):590-8.
7. Ibanez 1995 Ibanez C, Carcas AJ, Frias J, Abad F. Activated charcoal increases digoxin elimination in patients. International Journal of Cardiology 1995;48(1):27-30.
8. Kirkpatrick 1991 Kirkpatrick CH. Allergic histories and reactions of patients treated with digoxin immune Fab (ovine) antibody. American Journal of Emergency Medicine 1991;9(2 SUPPL. 1):7-10.
9. Lavaux 2004 Lavaux T, Assemi P, Casset A, Lavigne T, Castelain V, Seydi A, et al. Efficiency of a non-equimolar neutralisation of digoxin by immune Fab therapy. Journal of Toxicology - Clinical Toxicology. 2004; Vol. 42:464-5.
10. Love 1998 Love JN, Sachdeva DK, Bessman ES, Curtis LA, Howell JM. A potential role for glucagon in the treatment of drug-induced symptomatic bradycardia. Chest 1998;114(1):323-6.
11. Montoya 1995 Montoya CMA, Escalante GP, Sauceda GJM, Marquez ELM, Gonzalez CH, Flores Alvarez E. Treatment of acute poisoning caused by carbamazepine, digoxin, and acetylsalicylic acid, with repeated doses of activated charcoal [El tratamiento de las intoxicaciones agudas causadas por carbamazepina, digoxina y acido acetilsalicilico, mediante la administracion de dosis repetidas de carbon activado]. Gaceta Médica de México 1995;131(3):349-54.
12. Oliveri 1971 Oliveri R, Balestrini AE. Evaluation of sodium diphenylhydantoin in arrhythmies associated with digitalis poisoning [Valoracion de la difenihidantoina sodica en arritmias asociadas a la intoxicacion digitalica]. Prensa Médica Argentina 1971;58(32):1613-7.
13. Reissell 1982 Reissell P, Manninen V. Effect of administration of activated charcoal and fibre on absorption, excretion and steady state blood levels of digoxin and digitoxin. Evidence for intestinal secretion of the glycosides. Acta Medica Scandinavica Supplementum 1982;668:88-90.
14. Roberts 2006 Roberts DM, Southcott E, Potter JM, Roberts MS, Eddleston M, Buckley NA. Pharmacokinetics of digoxin cross-reacting substances in patients with acute yellow oleander (Thevetia peruviana) poisoning, including the effect of activated charcoal. Submitted 2006.
15. Schaumann 1986 Schaumann W, Kaufmann B, Neubert P, Smolarz A. Kinetics of the Fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication. European Journal of Clinical Pharmacology 1986;30(5):527-33.
16. Smith 1982 Smith TW, Butler VP Jr, Haber E, Fozzard H, Marcus FI, Bremner WF, et al. Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases. New England Journal of Medicine 1982;307(22):1357-62.
17. Smith 1991 Smith TW. Review of clinical experience with digoxin immune Fab (ovine). American Journal of Emergency Medicine 1991;9(2 Suppl 1): 1-6.
18. Smolarz 1984 Smolarz A, Roesch E, Lenz H. Report on the treatment of 16 cases of severe glycoside poisoning with sheep antidigoxin fragments (Fab) [Erfahrungsbericht uber die behandlung von 16 schweren glykosidvergiftungen mit digitalis antikorper fragmenten (Fab)]. Zeitschrift Fur Kardiologie 1984;73(2):113-9.
19. Taboulet 1993b Taboulet P, Baud FJ, Bismuth C, Vicaut E. Acute digitalis intoxication - Is pacing still appropriate?. Journal of Toxicology - Clinical Toxicology 1993;31(2):261-73.
20. Wenger 1985 Wenger TL, Butler VP Jr, Haber E, Smith TW. Treatment of 63 severely digitalis-toxic patients with digoxin-specific antibody fragments. Journal of the American College of Cardiology 1985;5(5 Suppl A):118A-123A.
21. Wenger 1991 Wenger TL. Experience with digoxin immune Fab (ovine) in patients with renal impairment. American Journal of Emergency Medicine 1991;9(2 Suppl 1):21-3.
22. Woolf 1991 Woolf AD, Wenger TL, Smith TW, Lovejoy FH Jr. Results of multicenter studies of digoxin-specific antibody fragments in managing digitalis intoxication in the pediatric population. American Journal of Emergency Medicine 1991;9(2 Suppl 1):16-20.
23. Woolf 1992 * Woolf AD, Wenger T, Smith TW, Lovejoy FH Jr. The use of digoxin-specific Fab fragments for severe digitalis intoxication in children. New England Journal of Medicine 1992;326(26):1739-44.
24. Eddleston 2005 Eddleston M, Juszczak E, Buckley NA, Senarathna L, Mohamed F, Sheriff MHS, Warrell DA. Randomised controlled trial of routine single or multiple dose superactivated charcoal for self-poisoning in a region with high mortality. Clinical Toxicology 2005;43:442-3.
25. Dawson 2006 Dawson AH. Fructose-1,6-diphosphate (FDP) in yellow oleander poisoning. Correspondence 2006.
26. Higgins 2005 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. http://www.cochrane.org/resources/handbook/hbook.htm.
27. Hoffman 2002 Hoffman RS. Non-pharmacological cardioactive steroids. Journal of Toxicology - Clinical Toxicology 2002;40(3):285-6.
28. Jadad 1996 Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of randomized clinical trials: Is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
29. Langford 1996 Langford SD, Boor PJ. Oleander toxicity: an examination of the human and animal toxic exposures. Toxicology 1996;109:1-13.
30. Markov 1999 Markov AK, Payment MF, Hume AS, Rao MR, Markov MA, Skelton TN, et al. Fructose-1,6-diphosphate in the treatment of oleander toxicity in dogs. Veterinary and Human Toxicology 1999;41(1):9-15.
31. Roberts 2005 Roberts DM, Eddleston M. Yellow oleander poisoning. In: Nayyar V editor(s). Critical Care Update 2004. 1. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd, 2005:189-200.
32. Schulz 1995 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association 1995;273(5):408-12.
33. Taboulet 1993a Taboulet P, Baud FJ, Bismuth C. Clinical features and management of digitalis poisoning - rationale for immunotherapy. Journal of Tox-icology - Clinical Toxicology 1993;31(2):247-60.